Wharton Alumni Angels
VC Fund
Fort Washington, United States
Wharton Alumni Angels is a VC fund in Fort Washington focused on Software and Machine Learning. Founded in 2016, Wharton Alumni Angels is an active angel investment group composed of University of Pennsylvania alumni and non-Penn alumni who have joined their angel community. Their members are entrepreneurs, senior business executives, and institutional investors with a global reach. Wharton Alumni Angels' over 200 members in 15countries have invested in more than 30 early stage companies in the past three years. Wharton Alumni Angels members seek to add value 'beyond the deal' and actively provide mentoring and assistance to young companies. They are enthusiastic about entrepreneurs and passionate teams pursuing their dreams. Through a global membership and the Wharton alumni community, the organization has a deep network and close relationships with venture capital funds, other angel networks, and innovation ecosystems worldwide to cultivate the growth of start-ups. Wharton Alumni Angels participates most often in seed and Series A investments, and occasionally later-stage rounds and does not focus on specific verticals or industries.
- Total investments:
- 34
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries Wharton Alumni Angels invests in
Stages Wharton Alumni Angels invests in
Countries Wharton Alumni Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $730k–$4.7M
- Pre-Seed
- $300k–$2.4M
- Series A
- $7.5M–$13M
Investment Focus
Industry
- Software 10 (29%)
- Machine Learning 9 (26%)
- Artificial Intelligence 9 (26%)
- SaaS 7 (21%)
- Health Care 6 (18%)
Stage
- Seed 14 (41%)
- Pre-Seed 4 (12%)
- Series A 3 (9%)
- Angel 2 (6%)
- Funding Round 2 (6%)
Country
- United States 19 (56%)
- Brazil 3 (9%)
- Canada 2 (6%)
- China 1 (3%)
- United Arab Emirates 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abhinav Asthana
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
Christina Kelmon
Member
|
Member | Total investments: 0 | Find email | |
Déa Wilson
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
Gerardo Zampaglione
Investor
|
Investor | Total investments: 0 | Find email | |
Jacky Chen
Managing Director (Canada)
|
Managing Director (Canada) | Total investments: 20 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cayuga Biotech
|
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayugais developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders. | $5M / Seed / Dec 11, 2025 | |
Alltius
|
Alltius's platform KNO allows product owners to harness the power of Generative AI in a secure, accurate, and reliable manner to add conversational capabilities to their products. KNO is currently being used as a no-code Help SaaS tool that is trained on product knowledge bases, support tickets, and video tutorials. It reduces the time peoplespend looking for answers by 100x, increasing customer NPS and reducing support costs by 40–70%. The "Humans of Alltius" include professors from CMU and the University. of California, consultants from BCG and McKinsey, and engineers from Facebook, Google, Rippling, and D.E. Shaw are driven by the obsession of augmenting human intelligence through AI. | $2.4M / Pre-Seed / May 30, 2023 | |
Secret Skin
|
Secret Skin is a value-driven discovery platform that connects conscious consumers to global Conscious beauty brands. | $765K / Pre-Seed / Dec 12, 2022 | |
Motion2AI
|
Motion2AI is an Artificial Intelligence (AI) software company that focuses on forklift tracking and forklift telematics. Our solutions proactively prevent forklift accidents, reduce labor costs, improve fleet utilization, and help warehouse managers make data-driven decisions. | $12.6M / Series A / Aug 17, 2021 | |
Fluid Biomed
|
Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. | $4.7M / Seed / Aug 11, 2021 | |
Agile Devices
|
Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies. | $1.4M / Mar 09, 2021 | |
|
Agile Devices
|
Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies. | $1.4M / Venture - Series Unknown / Mar 09, 2021 | |
DarwinAI
|
DarwinAI is the next evolution in A.I. development. Based on distinguished scholarship by an award-winning team led by a Canada Research Chair in A.I., DarwinAI takes the guesswork out of building better A.I. Through our patented Generative Synthesis™ A.I.-building A.I., DarwinAI enables A.I. to work in the real world by making deep learningfaster, portable, scalable, and understandable. Making A.I. work for anyone, anywhere, anytime. | Seed / Jan 06, 2021 | |
Pinktada
|
Pinktada is a primary and secondary market for hotel rooms, architected on tokenization. Pinktada transforms hotel booking by enabling tokenization in the travel market. The company was founded in 2020 and is based in Houston, Texas. | $415K / Pre-Seed / Jan 05, 2021 | |
|
DarwinAI
|
DarwinAI is the next evolution in A.I. development. Based on distinguished scholarship by an award-winning team led by a Canada Research Chair in A.I., DarwinAI takes the guesswork out of building better A.I. Through our patented Generative Synthesis™ A.I.-building A.I., DarwinAI enables A.I. to work in the real world by making deep learningfaster, portable, scalable, and understandable. Making A.I. work for anyone, anywhere, anytime. | $5.9M / Seed / Dec 15, 2020 | |
| See all 34 investments → | |||
Co-Investors
Mir Ventures
3 deals together
Third Sphere
3 deals together
Alchemist Accelerator
2 deals together
Ekistic Ventures
2 deals together
FuturePlay
2 deals together
GIC
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Wharton Alumni Angels invest in?
Wharton Alumni Angels invests primarily in Software, Machine Learning and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 34 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Wharton Alumni Angels's check size?
Wharton Alumni Angels typically joins rounds of $730k–$4.7M at Seed, $300k–$2.4M at Pre-Seed and $7.5M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wharton Alumni Angels participates in.
How do I contact Wharton Alumni Angels?
Public channels for Wharton Alumni Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wharton Alumni Angels?
The team at Wharton Alumni Angels includes Abhinav Asthana (Angel Investor), Christina Kelmon (Member) and Déa Wilson (Angel Investor), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
